SciELO - Scientific Electronic Library Online

 
vol.43 suppl.1Alcohol prevention within primary care in municipalities in the state of Minas Gerais, Southeastern BrazilCognitive behavioral group therapy for sexually abused girls author indexsubject indexarticles search
Home Page  

Revista de Saúde Pública

Print version ISSN 0034-8910

Abstract

LINDNER, Leandro Mendonça; MARASCIULO, Antonio Carlos; FARIAS, Mareni Rocha  and  GROHS, Geder Evandro Motta. Economic evaluation of antipsychotic drugs for schizophrenia treatment within the Brazilian Healthcare System. Rev. Saúde Pública [online]. 2009, vol.43, suppl.1, pp. 62-69. ISSN 0034-8910.

OBJECTIVE: To assess the cost-utility of first and second-generation antipsychotics for treatment of schizophrenia. METHODS: A five-year Markov model was constructed based on a survey of the records of patients seen in 2006 at a psychosocial care center in the municipality of Florianopolis, Southern Brazil. Costs were evaluated from the perspective of the Sistema Único de Saúde (SUS - Unified Healthcare System). Utility was measured in quality-adjusted life years obtained in the literature. RESULTS: The Markov model indicated risperidone and haloperidol utilization before olanzapine as the most cost-effective alternatives. CONCLUSIONS: Antipsychotic agents haloperidol and risperidone are more cost-effective than olanzapine. Strategies prioritizing the use of antipsychotics with better cost-effectiveness could optimize resource allocation without necessarily compromising the health of patients treated through the Sistema Único de Saúde.

Keywords : Antipsychotic Agents; Schizophrenia; Health Care Costs Quality-Adjusted Life Years; Single Health System; Cost-Effectiveness Evaluation.

        · abstract in Portuguese | Spanish     · text in English | Portuguese     · pdf in English | Portuguese